2022

Ayshwarya Subramanian decodes cellular diversity in complex human diseases across cells and systems.

Constantine Tzouanas applies new technologies, such as spatial imaging tools, to elucidate how cells perform system-level functions in both health and disease.

Fadi Najm deploys molecular tools, like the CRISPR gene-editing technology, to identify therapeutic targets in cancer and immunotherapy.

Sam Freidman wields his machine learning expertise to build models that can both drive foundational research and impact clinical care, such as predicting risk for common heart conditions like heart arrhythmias.

Sumaiya Iqbal bridges genetics and proteomics with data science and machine learning in the quest for new therapeutics.

Augustin Luna develops statistical and mechanistic models to see how cancer cells respond to small molecules and genetic perturbations.

Yakir Reshef is decoding the immune system to hone the precision of clinical assessments.